Clocinizine
- Level
- Commodity
- Parent
- 51313100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313103This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8HQJ711KH8. European Medicines Agency schedules Clocinizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06685MIG. Clocinizine generally arises in the molecular formula C26H27CLN2. The term CLOCINIZINE is an International Non-Proprietary Name or INN. CLOCINIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clocinizine under HS 29335995 and SITC 51576. As of Q4 2014, CLOCINIZINE remains the US FDA Preferred Term for this commodity. Clocinizine bears US NLM identifiers UMLS ID C1322002 and NCI Concept Code C77435. SMILES: CLC1CCC(C(N2CCN(CC2)C/C=C/C2CCCCC2)C2CCCCC2)CC1.
Same parent
Under 51313100 · 20Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.